NEA Management Company, LLC Q4 2025 Filing
Filed February 17, 2026
Portfolio Value
$2.0T
Holdings
27
Report Date
Q4 2025
Filing Type
13F-HR
All Holdings (27 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | CELCCelcuity Inc. | 3,535,561 | $352.6B | 17.98% | |
| 2 | RYTMRhythm Pharmaceuticals, Inc. | 2,909,956 | $311.5B | 15.88% | |
| 3 | ACLXArcellx, Inc. | 3,045,262 | $198.6B | 10.12% | |
| 4 | TRVITrevi Therapeutics, Inc. | 13,222,228 | $165.5B | 8.44% | |
| 5 | YB4PSavara, Inc. | 24,471,264 | $147.6B | 7.52% | |
| 6 | ZBIOZenas BioPharma, Inc. | 3,523,219 | $127.9B | 6.52% | |
| 7 | GLUEMonte Rosa Therapeutics, Inc. | 7,692,298 | $120.6B | 6.15% | |
| 8 | MBXMBX Biosciences, Inc. | 3,614,486 | $114.0B | 5.81% | |
| 9 | COURCoursera, Inc. | 12,867,769 | $94.7B | 4.83% | |
| 10 | AUPHAurinia Pharmaceuticals, Inc. | 3,969,834 | $63.3B | 3.23% | |
| 11 | GOSSGossamer Bio, Inc. | 18,093,034 | $56.1B | 2.86% | |
| 12 | CRSPCRISPR Therapeutics AG | 1,058,570 | $55.5B | 2.83% | |
| 13 | ORICORIC Pharmaceuticals, Inc. | 4,118,621 | $33.7B | 1.72% | |
| 14 | PHATPhathom Pharmaceauticals, Inc. | 1,960,169 | $32.5B | 1.66% | |
| 15 | CVRXCVRx, Inc. | 2,026,083 | $14.4B | 0.73% | |
| 16 | ASNSUSDX4 Pharmaceuticals, Inc. | 3,233,743 | $12.9B | 0.66% | |
| 17 | CSBRChampions Oncology, Inc. | 1,713,720 | $11.8B | 0.60% | |
| 18 | BDTXBlack Diamond Therapeutics, Inc. | 4,448,757 | $10.8B | 0.55% | |
| 19 | KRROKorro Bio, Inc. | 1,090,793 | $8.7B | 0.45% | |
| 20 | IVAInventiva SA | 1,462,586 | $6.8B | 0.35% | |
| 21 | NKTXNkarta, Inc. | 3,568,781 | $6.6B | 0.34% | |
| 22 | SNTISenti Biosciences, Inc. | 3,775,615 | $3.9B | 0.20% | |
| 23 | LONALeonaBio, Inc. | 464,398 | $3.5B | 0.18% | |
| 24 | SYBXSynlogic, Inc. | 2,922,772 | $3.3B | 0.17% | |
| 25 | MRKRMarker Therapeutics, Inc. | 1,625,678 | $2.4B | 0.12% | |
| 26 | OKUROnKure Therapeutics, Inc. | 478,548 | $1.4B | 0.07% | |
| 27 | IMAImageneBio, Inc. | 50,005 | $345.0M | 0.02% |